55 filings
13F-NT
Marshall Wace North America L.P.
14 Feb 24
Notice of holdings reported by another manager
5:12pm
SC 13G/A
Marshall Wace North America L.P.
14 Feb 24
Acrivon Therapeutics / Marshall Wace North America ownership change
9:51am
13F-NT
Marshall Wace North America L.P.
14 Nov 23
Notice of holdings reported by another manager
12:00am
13F-NT
Marshall Wace North America L.P.
14 Aug 23
Notice of holdings reported by another manager
4:21pm
SC 13G
NSPR
InspireMD Inc
22 May 23
InspireMD / Marshall Wace North America ownership change
4:15pm
13F-NT
zkhvwu
15 May 23
Notice of holdings reported by another manager
3:28pm
13F-NT
a4d0qsnml1d5uaruy
14 Feb 23
Notice of holdings reported by another manager
2:43pm
SC 13G
yfiupsl y4llr83b0
14 Feb 23
Acrivon Therapeutics / Marshall Wace North America ownership change
9:35am
13F-NT
ln3pq
14 Nov 22
Notice of holdings reported by another manager
4:00pm
13F-NT
20hwgq
15 Aug 22
Notice of holdings reported by another manager
3:19pm
13F-NT
8icmvyuzjk
16 May 22
Notice of holdings reported by another manager
11:29am
13F-NT
ugjj5a
14 Feb 22
Notice of holdings reported by another manager
12:00am
13F-HR
7a4yj 8obe02
15 Nov 21
Quarterly holdings report by institutional manager
12:00am
13F-HR/A
xgpf edvqr9
27 Aug 21
Quarterly holdings report by institutional manager (amended)
12:00am
13F-HR/A
1v3895q4dd ufj16ek8w
27 Aug 21
Quarterly holdings report by institutional manager (amended)
12:00am
13F-HR/A
hac36rh9w4bgey lnqd
26 Aug 21
Quarterly holdings report by institutional manager (amended)
4:15pm
13F-HR/A
gbajapqx9e8p5o4qd1q
26 Aug 21
Quarterly holdings report by institutional manager (amended)
4:11pm
13F-HR/A
rlqgn2n
25 Aug 21
Quarterly holdings report by institutional manager (amended)
4:40pm
13F-HR/A
1sg3n
25 Aug 21
Quarterly holdings report by institutional manager (amended)
4:35pm
13F-HR
7nnupkehsgxy t3lxk60
13 Aug 21
Quarterly holdings report by institutional manager
3:49pm